Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)
Study sponsor: Aclaris Therapeutics, Inc. · ACRS
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2021-02-25Actual
Enrollment · participants1Actual
Source updated2023-09-21Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.